X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
dti-015 (6) 6
bcnu (4) 4
brain neoplasms - drug therapy (4) 4
oncology (4) 4
intratumoral (3) 3
malignant glioma (3) 3
animals (2) 2
brain neoplasms - pathology (2) 2
carmustine (2) 2
carmustine - administration & dosage (2) 2
chemotherapy (2) 2
chromatography, high pressure liquid (2) 2
clinical neurology (2) 2
drug-delivery (2) 2
ethanol (2) 2
glioblastoma - drug therapy (2) 2
humans (2) 2
index medicus (2) 2
injections, intralesional (2) 2
intraarterial (2) 2
male (2) 2
radiotherapy (2) 2
rats (2) 2
recurrent malignant glioma (2) 2
stereotactic injection (2) 2
t9 gliosarcoma (2) 2
trial (2) 2
tumor (2) 2
tumor cells, cultured (2) 2
1--1-nitrosourea (1) 1
abridged index medicus (1) 1
aged (1) 1
antineoplastic agents, alkylating - administration & dosage (1) 1
antineoplastic agents, alkylating - metabolism (1) 1
antineoplastic agents, alkylating - pharmacokinetics (1) 1
antineoplastic agents, alkylating - therapeutic use (1) 1
basic and translational investigations (1) 1
blood-brain barrier (1) 1
blood-brain-barrier (1) 1
blood-volume (1) 1
brain mapping (1) 1
brain neoplasms - diagnostic imaging (1) 1
brain neoplasms - metabolism (1) 1
brain neoplasms - radiotherapy (1) 1
brain-tumors (1) 1
cancer (1) 1
cancer research (1) 1
carmustine - metabolism (1) 1
carmustine - pharmacokinetics (1) 1
carmustine - pharmacology (1) 1
carmustine - therapeutic use (1) 1
cerebrovascular circulation - drug effects (1) 1
chemoradiotherapy (1) 1
clinical trial (1) 1
clinical trials (1) 1
contrast media (1) 1
convection-enhanced delivery (1) 1
cross-linking reagents (1) 1
ct imaging (1) 1
delivery (1) 1
dextrose (1) 1
diffusion (1) 1
disease progression (1) 1
disease-free survival (1) 1
dna alkylation (1) 1
dna alkylation products (1) 1
dna, neoplasm - metabolism (1) 1
docetaxel (1) 1
drug delivery systems (1) 1
drugs (1) 1
efficacy (1) 1
enhanced delivery (1) 1
erlotinib (1) 1
feasibility studies (1) 1
female (1) 1
fluorodeoxyglucose f18 (1) 1
gadolinium dtpa (1) 1
gefitinib (1) 1
glioblastoma (1) 1
glioblastoma - metabolism (1) 1
glioblastoma - pathology (1) 1
glioblastoma multiforme (1) 1
glioma - diagnostic imaging (1) 1
glioma - drug therapy (1) 1
glioma - radiotherapy (1) 1
gliomas (1) 1
gliosarcoma - drug therapy (1) 1
gliosarcoma - pathology (1) 1
glucose (1) 1
grade glioma (1) 1
guanine - administration & dosage (1) 1
guanine - analogs & derivatives (1) 1
human-brain-tumors (1) 1
injection (1) 1
injections, intramuscular - methods (1) 1
intratumoral injection (1) 1
karnofsky performance status (1) 1
magnetic resonance imaging (1) 1
magnetic resonance imaging - methods (1) 1
malignant gliomas (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Translational Oncology, ISSN 1936-5233, 2014, Volume 7, Issue 2, pp. 303 - 308
Abstract BACKGROUND: Efficacy of second-line chemotherapy in platinum-pretreated non–small cell lung cancer (NSCLC) is poor. This study investigated efficacy... 
Oncology | PHASE-III TRIAL | MULTICENTER | GEFITINIB | ONCOLOGY | BCNU | TUMOR | DTI-015 | DOCETAXEL | ERLOTINIB
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 8/2010, Volume 99, Issue 1, pp. 103 - 113
Journal Article
Neoplasia (New York, N.Y.), ISSN 1522-8002, 1/2003, Volume 5, Issue 1, pp. 17 - 22
DTI-015 (BCNU in 100% ethanol) utilizes solvent-facilitated perfusion for the intratumoral treatment of gliomas. The water-miscible organic solvent vehicle,... 
DTI-015 | stereotactic injection | T9 gliosarcoma | malignant glioma | intratumoral
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.